Global Clinical Immunoanalyzer Market growing at a CAGR of 5.0% from 2023 to 2030
Category : Healthcare | Published Date : Aug 2023 | Type : Press Release
Key Market Overview
Consegic Business Intelligence analyzes that the clinical immunoanalyzer market is predicted to grow at a compound annual growth rate of 5.0% from 2023 to 2030 and is expected to reach USD 7,045.57 million in 2030 which was valued at USD 4,792.13 million in 2022.
The report highlights the increasing adoption of clinical immunoanalyzer in hospitals, which is proliferating global market growth. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the clinical immunoanalyzer market.
Global Clinical Immunoanalyzer Market By Overview
The clinical immunoanalyzer market is bifurcated into product type and end user. Based on product type, the market is segmented into chemiluminescent immunoassay (CLIA), enzyme linked immunosorbent assay (ELISA), fluorescence immunoassay analyser (FIA), and others. In 2022, the chemiluminescent immunoassay (CLIA) segment dominates in the overall clinical immunoanalyzer market. The end user segment is categorized into hospitals, diagnostic labs, clinics, and others. In 2022, the hospitals segment accounted for the highest market share in the clinical immunoanalyzer market.
Get Free SampleMarket Dynamics
Driver:
- The rising adoption of clinical immunoanalyzer in hospitals is bolstering the market growth at the global level.
- Booming technological advancements is favoring the global clinical immunoanalyzer market growth.
Restraints:
- Stringent regulations for clinical immunoanalyzer testing are restraining the market growth.
Market Segmentation:
| Report Attributes | Report Details |
| By Product Type | Chemiluminescent immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay Analyser (FIA), and Others |
| By End User | Hospitals, Diagnostic Labs, Clinics, and Others |
| By Region | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Competitive Landscape :
The market is dominated by certain major companies such as Roche Diagnostics, Abbott, Beckman Coulter, and BioMerieux which have a strong market position in current market circumstances. These companies are continuously leveraging new technologies to develop innovative solutions. Furthermore, the clinical immunoanalyzer market is expected to witness substantial growth in the coming years due to the growing investment in new clinical immunoanalyzer range in key regions such as North America, Asia Pacific, and others.
The market is characterized by intense competition, with companies focusing on expanding their product offerings and increasing their market share through mergers, acquisitions, and partnerships.
- Roche Diagnostics
- Abbott
- Beckman Coulter
- BioMerieux
- Randox Laboratories
- Tosoh Corporation
- Werfen Life
- DiaSorin
- BioMerieux
- Ortho-Clinical Diagnostics
